Professor Christopher Buckley, University of Birmingham and University of Oxford, UK
Professor Harris Perlman, Northwestern University, USA
Click here to view which articles have been shared the most in the last month.
Meet this month's featured authors!
Aims and scope
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Meta-analysis of pain and function placebo responses in pharmacological osteoarthritis trials
Current treatments of osteoarthritis (OA) mainly focus on relieving pain and stiffness or improving function and quality of life. High placebo responses (PRs) in OA trials are believed to have contributed to the long list of failures of OA trials to date.
In this meta-analysis review, Huang et al evaluate the contextual effects in the form of PRs for patient reported pain and function, and objectively measured function in clinical trials of OA of the knee, hip, foot, or hand.
Annual Journal Metrics
56 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
121 days from submission to acceptance
33 days from acceptance to publication
1,140 Altmetric Mentions